Tech-enabled infusion provider Local Infusion bagged $10 million in Series A funding, CEO Woody Baum tells Axios exclusively.
Why it matters: Investors have been eager to pump funds into infusion networks outside hospitals to disrupt a $100 billion-plus market that's been historically dominated by OptumRx and Option Care Health.
